214 related articles for article (PubMed ID: 23018647)
21. The mitochondria-targeted imidazole substituted oleic acid 'TPP-IOA' affects mitochondrial bioenergetics and its protective efficacy in cells is influenced by cellular dependence on aerobic metabolism.
Maddalena LA; Ghelfi M; Atkinson J; Stuart JA
Biochim Biophys Acta Bioenerg; 2017 Jan; 1858(1):73-85. PubMed ID: 27836699
[TBL] [Abstract][Full Text] [Related]
22. Thiostrepton selectively targets breast cancer cells through inhibition of forkhead box M1 expression.
Kwok JM; Myatt SS; Marson CM; Coombes RC; Constantinidou D; Lam EW
Mol Cancer Ther; 2008 Jul; 7(7):2022-32. PubMed ID: 18645012
[TBL] [Abstract][Full Text] [Related]
23. Targeting FoxM1 inhibits proliferation, invasion and migration of nasopharyngeal carcinoma through the epithelial‑to-mesenchymal transition pathway.
Yu C; Chen L; Yie L; Wei L; Wen T; Liu Y; Chen H
Oncol Rep; 2015 May; 33(5):2402-10. PubMed ID: 25738652
[TBL] [Abstract][Full Text] [Related]
24. Activation of the FOXM1/ASF1B/PRDX3 axis confers hyperproliferative and antioxidative stress reactivity to gastric cancer.
Zhao Z; Cai Z; Zhang S; Yin X; Jiang T; Shen C; Yin Y; Sun H; Chen Z; Han J; Zhang B
Cancer Lett; 2024 May; 589():216796. PubMed ID: 38537775
[TBL] [Abstract][Full Text] [Related]
25. Quinoline-based clioquinol and nitroxoline exhibit anticancer activity inducing FoxM1 inhibition in cholangiocarcinoma cells.
Chan-On W; Huyen NT; Songtawee N; Suwanjang W; Prachayasittikul S; Prachayasittikul V
Drug Des Devel Ther; 2015; 9():2033-47. PubMed ID: 25897210
[TBL] [Abstract][Full Text] [Related]
26. Peroxiredoxin 3 is a key molecule regulating adipocyte oxidative stress, mitochondrial biogenesis, and adipokine expression.
Huh JY; Kim Y; Jeong J; Park J; Kim I; Huh KH; Kim YS; Woo HA; Rhee SG; Lee KJ; Ha H
Antioxid Redox Signal; 2012 Feb; 16(3):229-43. PubMed ID: 21902452
[TBL] [Abstract][Full Text] [Related]
27. Thiazole antibiotics target FoxM1 and induce apoptosis in human cancer cells.
Bhat UG; Halasi M; Gartel AL
PLoS One; 2009; 4(5):e5592. PubMed ID: 19440351
[TBL] [Abstract][Full Text] [Related]
28. Antiproliferative effects of mitochondria-targeted cationic antioxidants and analogs: Role of mitochondrial bioenergetics and energy-sensing mechanism.
Cheng G; Zielonka J; McAllister D; Hardy M; Ouari O; Joseph J; Dwinell MB; Kalyanaraman B
Cancer Lett; 2015 Aug; 365(1):96-106. PubMed ID: 26004344
[TBL] [Abstract][Full Text] [Related]
29. Mdivi-1 ameliorates early brain injury after subarachnoid hemorrhage via the suppression of inflammation-related blood-brain barrier disruption and endoplasmic reticulum stress-based apoptosis.
Fan LF; He PY; Peng YC; Du QH; Ma YJ; Jin JX; Xu HZ; Li JR; Wang ZJ; Cao SL; Li T; Yan F; Gu C; Wang L; Chen G
Free Radic Biol Med; 2017 Nov; 112():336-349. PubMed ID: 28790012
[TBL] [Abstract][Full Text] [Related]
30. Peroxiredoxin 3 maintains the survival of endometrial cancer stem cells by regulating oxidative stress.
Song IS; Jeong YJ; Seo YJ; Byun JM; Kim YN; Jeong DH; Han J; Kim KT; Jang SW
Oncotarget; 2017 Nov; 8(54):92788-92800. PubMed ID: 29190956
[TBL] [Abstract][Full Text] [Related]
31. Over-expression of FoxM1 is associated with adverse prognosis and FLT3-ITD in acute myeloid leukemia.
Liu LL; Zhang DH; Mao X; Zhang XH; Zhang B
Biochem Biophys Res Commun; 2014 Mar; 446(1):280-5. PubMed ID: 24582753
[TBL] [Abstract][Full Text] [Related]
32. Negative modulation of mitochondrial oxidative phosphorylation by epigallocatechin-3 gallate leads to growth arrest and apoptosis in human malignant pleural mesothelioma cells.
Valenti D; de Bari L; Manente GA; Rossi L; Mutti L; Moro L; Vacca RA
Biochim Biophys Acta; 2013 Dec; 1832(12):2085-96. PubMed ID: 23911347
[TBL] [Abstract][Full Text] [Related]
33. Unique fractal evaluation and therapeutic implications of mitochondrial morphology in malignant mesothelioma.
Lennon FE; Cianci GC; Kanteti R; Riehm JJ; Arif Q; Poroyko VA; Lupovitch E; Vigneswaran W; Husain A; Chen P; Liao JK; Sattler M; Kindler HL; Salgia R
Sci Rep; 2016 Apr; 6():24578. PubMed ID: 27080907
[TBL] [Abstract][Full Text] [Related]
34. The transcription factor FOXM1 is a cellular target of the natural product thiostrepton.
Hegde NS; Sanders DA; Rodriguez R; Balasubramanian S
Nat Chem; 2011 Aug; 3(9):725-31. PubMed ID: 21860463
[TBL] [Abstract][Full Text] [Related]
35. Mitochondria-Division Inhibitor 1 Protects Against Amyloid-β induced Mitochondrial Fragmentation and Synaptic Damage in Alzheimer's Disease.
Reddy PH; Manczak M; Yin X
J Alzheimers Dis; 2017; 58(1):147-162. PubMed ID: 28409745
[TBL] [Abstract][Full Text] [Related]
36. To mdivi-1 or not to mdivi-1: Is that the question?
Smith G; Gallo G
Dev Neurobiol; 2017 Nov; 77(11):1260-1268. PubMed ID: 28842943
[TBL] [Abstract][Full Text] [Related]
37. Mitochondria-targeted nitroxides exacerbate fluvastatin-mediated cytostatic and cytotoxic effects in breast cancer cells.
Cheng G; Lopez M; Zielonka J; Hauser AD; Joseph J; McAllister D; Rowe JJ; Sugg SL; Williams CL; Kalyanaraman B
Cancer Biol Ther; 2011 Oct; 12(8):707-17. PubMed ID: 21799303
[TBL] [Abstract][Full Text] [Related]
38. Repression of the mitochondrial peroxiredoxin antioxidant system does not shorten life span but causes reduced fitness in Caenorhabditis elegans.
Ranjan M; Gruber J; Ng LF; Halliwell B
Free Radic Biol Med; 2013 Oct; 63():381-9. PubMed ID: 23722165
[TBL] [Abstract][Full Text] [Related]
39. Expression of FoxM1 is required for the proliferation of medulloblastoma cells and indicates worse survival of patients.
Priller M; Pöschl J; Abrão L; von Bueren AO; Cho YJ; Rutkowski S; Kretzschmar HA; Schüller U
Clin Cancer Res; 2011 Nov; 17(21):6791-801. PubMed ID: 21918172
[TBL] [Abstract][Full Text] [Related]
40. FoxM1 inhibitors as potential anticancer drugs.
Gartel AL
Expert Opin Ther Targets; 2008 Jun; 12(6):663-5. PubMed ID: 18479213
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
